Diagnosis of FVII Padua (Arg304Gln) by means of simple clotting tests

Clinica Chimica Acta

Volumn 411, Issue 23-24, 2010, Pages 2107-2108

  Girolami, A ^a   Berti de Marinis, G ^a   Bonamigo, E ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Arg304Gln mutation; FVII activation; FVII levels; Tissue thromboplastins

Indexed keywords

BLOOD CLOTTING FACTOR 7; THROMBOPLASTIN;

BLOOD CLOTTING FACTOR 7 DEFICIENCY; BRAIN; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ELECTROENCEPHALOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; LETTER; MEDICAL RESEARCH; MOLECULAR BIOLOGY; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTHROMBIN TIME; RABBIT; THROMBOTEST;

AMINO ACID SUBSTITUTION; ANIMALS; BLOOD COAGULATION; DNA MUTATIONAL ANALYSIS; FACTOR VII; FEMALE; HUMANS; PREGNANCY; RABBITS;

EID: 77957750989     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.08.015     Document Type: Letter

References (14)

1. Perry D.J. Factor VII Deficiency. Br J Haematol 2002, 118:689-700.
2. Girolami A., Fabris F., Dal Bo Zanon R., Ghiotto G. Burul A. Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med 1978, 91:387-395.
3. Girolami A., Patrassi G., Cappellato G., Casonato A. Another family with the Factor VII Padua clotting defect. Acta Haematol 1979, 62:4-11.
4. Girolami A., Gaio A., Procidano M., Saltarin P. Further studies on FVII Padua defect: the report of the fourth homozygous patient. Blut 1982, 44:363-369.
5. Girolami A., Dal Bo Zanon R., Caenazzo A., Scattolo N. Report of the fifth homozygous patient with FVII Padua defect. Folia Haematol 1983, 110:447-454.
6. James H.L., Kumar A., Girolami A., Hubbard J.G., Fair D.S. Variant coagulation factor X and VII point mutations in a highly conserved model in the substrate binding pocket. Comparative molecular modeling. Thromb Haemost 1991, 65:137. (Abstract Book).
7. James H., Girolami A., Hubbard J.G., Kumar A., Fair D.S. The dysfunction of coagulation factor VII Padua results from substitution of arginine 304 with glutamine. Chem Biophys Acta 1993, 1172:301-305.
8. O'Brien D.P., Gale K.M., Anderson J.S., et al. Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male. Blood 1991, 78:132-140.
9. Fromovich-Amit Y., Zivelin A., Rosenberg N., Landau M., Rosa J.P., Seligsohn U. Of four mutations in the factor VII gene in Tunisian patients, one novel mutation (Ser339Phe) in three unrelated families abrogates factor X activation. Blood Coagul Fibrinolysis 2005, 16:369-374.
10. Giansily-Blaizot M., Aguilar-Martinez P., Biron-Andreani C., Jeanjean P., Igual H. Study Group of Factor Seven Deficiency. Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency. Eur J Hum Genet 2001, 9:105-112.
11. Takamiya O., McVey I., Kemhell-Cook G., Tuddenham E. Dysfunctional human FVII variants and single-strand conformational polymorphism (SSC5). Thromb Hemost 1993, 69:1291. (Suppl).
12. Tahatahary A., Ravanbod S., Baghaipour M., Enayar M., Ala F., Rastager-Iari Factor VII genotype and clinical profile in 6 Iranian patients with congenital factor VII deficiency. J Thromb Hemost 2007, 5:208. Suppl.
13. Sabharwal A., KuppusWarmy M., Foster D. Factor VII deficiency (FVII Richmond) associated with thrombosis. Circul 1992, 88:679. (Suppl).
14. Matsushita T., Kojima T., Emi N., Takahashi I., Saito H. Impaired human tissue factor mediated activity in blood clotting Factor VII Nagoya (Arg304Trp). J Biol Chem 1994, 269:7355-7363.